Gastric acidity inhibitors and the risk of intestinal infections

Current Opinion in Gastroenterology

Volumn 26, Issue 1, 2010, Pages 31-35

  Berni Canani, Roberto ^a   Terrin, Gianluca ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Clostridium difficile; Diarrhea; Histamine 2 receptor antagonists; Neonates; Proton pump inhibitors

Indexed keywords

DEXAMETHASONE; GASTRIC ACID INHIBITOR; HISTAMINE H2 RECEPTOR ANTAGONIST; OMEPRAZOLE; PROTON PUMP INHIBITOR; RANITIDINE; STOMACH SECRETION INHIBITOR; UNCLASSIFIED DRUG;

ACUTE GASTROENTERITIS; BLOODSTREAM INFECTION; CLINICAL TRIAL; CLOSTRIDIUM DIFFICILE INFECTION; COST EFFECTIVENESS ANALYSIS; DIARRHEA; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL INFECTION; HELICOBACTER INFECTION; HUMAN; INFECTION SENSITIVITY; INTESTINE INFECTION; MENINGITIS; NECROTIZING ENTEROCOLITIS; PNEUMONIA; REVIEW; SEPSIS; STOMACH ACID SECRETION; STOMACH PH; STRONGYLOIDIASIS; VERY LOW BIRTH WEIGHT;

ADULT; AGE FACTORS; ANTI-ULCER AGENTS; CASE-CONTROL STUDIES; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; GASTRIC ACID; GASTRIC ACIDITY DETERMINATION; GASTROENTERITIS; HUMANS; HYDROGEN-ION CONCENTRATION; INCIDENCE; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; MALE; PROTON PUMP INHIBITORS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT;

EID: 74249102455     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOG.0b013e328333d781     Document Type: Review

References (19)

1. Martinsen TC, Bergh K, Waldum HL. Gastric juice: a barrier against infectious diseases. Basic Clin Pharm Toxicol 2005; 96:94-102.
2. Dial MS. Proton pump inhibitor use and enteric infections. Am J Gastroenterol 2009; 104:S10-S16.
3. Leonard J, Marshall JK, Moayyedi P. Systematic review of the risk of enteric infection in patients taking acid suppression. Am J Gastroenterol 2007; 102:2047-2056.
4. Muir Gray JA. Evidences-based healthcare: how to make health policy and management decisions. London: Churchill Livingstone; 1997.
5. Garcia Rodriguez LA, Ruigomez A, Panes J. Use of acid-suppressing drugs and the risk of bacterial gastroenteritis. Clin Gastroenterol Hepatol 2007; 5:1418-1423.
6. Doorduyn Y, Van Pelt W, Siezen CLE, et al. Novel insight in the association between salmonellosis or campylobacteriosis and chronic illness, and the role of host genetics in susceptibility to these diseases. Epidemiol Infect 2008; 136:1225-1234.
7. Forssman B, Mannes T, Musto J, et al. Vibrio cholerae O1 El Tor cluster in Sydney linked to imported whitebait. Med J Aust 2007; 187:345-347.
8. Khatami SS, Mukunda B, Ravakhah K. Coinfection with Giardia lamblia and Clostridium diffcile after use of ranitidine. Am J Med Sci 2004; 327:91-93.
9. Cadle RM, Mansouri MD, Logan N, et al. Association of proton-pump inhibitors with outcomes in Clostridium difficile colitis. Am J Health Syst Pharm 2007; 64:2359-2363.
10. Doorduyn Y, Van Den Bradhof WE, Van Duynhoven YTHP, et al. Risk factors for Samonella enteritidis and Typhimurium (DT104 and non-DT104) infections in the Netherlands: predominant roles for raw eggs in Enteritidis and sandboxes in Typhimurium infections. Epidemiol Infect 2006; 134:617-626.
11. Berni Canani R, Cirillo P, Roggero P, et al. Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children. Pediatrics 2006; 117:e817-e820.
12. Vakil N. Acid inhibition and infections outside the gastrointestinal tract. Am J Gastroenterol 2009; 104:S17-S20.
13. Conroy S, McIntyre J. The use of unlicensed and off-label medicines in the neonate. Semin Fetal Neonatal Med 2005; 10:115-122.
14. Guillet R, Stoll BJ, Cotton CM, et al. For members of the National Institute of Child Health and Human Development Neonatal Research Network. Association of H2-blocker therapy and higher incidence of necrotizing enterocolitis in very low birth weight infants. Pediatrics 2006; 117:137-142.
15. Stoll BJ, Temprosa M, Tyson JE, et al. Dexamethasone therapy increases infection in very low birth weight infants. Pediatrics 1999; 104:e63.
16. Beck-Sague CM, Aximi P, Fonseca SN, et al. Bloodstream infections in neonatal intensive care unit patients: results of multicenter study. Pediatr Infect Dis J 1994; 13:1110-1116.
17. Handley SA, Dube PH,Miller VL. Histamine signaling through the H2 receptor in the Peyer's patch is important for controlling Yersinia enterocolitica infection. Proc Natl Acad Sci U S A 2006; 103:9269-9273.
18. Schubert ML, Peura DA. Control of gastric acid secretion in health and disease. Gastroenterology 2008; 134:1842-1860.
19. IMS Health National Sale Prescription Web site. 2004 Year-End US Prescription and Sales Information and Commentary. http://www.imshealthca nada.com/htmen/3-2-28.htm. (Accessed 21 November 2005)